fashion -WSS

fashion

author：knowledge 2025-09-30 22:04:31 - browse：79

Matts Take Column Illustration — Molly Ferguson for STAT

If you’re a drug company executive, you probably feel like you got up on the wrong side of bed.

On Thursday night, President Biden proposed expanding one of his most popular policies: the Medicare price negotiation process that was put in place as part of the Inflation Reduction Act. “Americans pay more for prescription drugs than anywhere else,” Biden said. “It’s wrong and I’m ending it.”

Obviously, the drug industry is not going to be happy about new price limitations in the U.S., the biggest market for pharmaceuticals. But, even more than that, Biden’s move emphasizes a painful reality: That pharmaceutical companies remain one of the biggest political targets in the country — despite their key role in addressing the Covid-19 pandemic and their development of wildly effective new weight loss drugs.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How one medical school became remarkably diverse
Next article： FDA clears AI tool for detecting skin cancer

leisure time

WSS

Research misconduct: Proposed new rules face resistance

New requirements coming in 2024 for Americans traveling to Europe

Independent physicians launch a new lobbying group

Woman found dead after suspected bear encounter near Yellowstone, wildlife officials say

My yearlong odyssey to get my son’s ADHD medication covered

Medicare Advantage today, explained in one chart

hotspot

fashion

leisure time

Virginia high school admissions case could be legal follow

NIH director takes cautious approach to Biden drug pricing priority

23andMe had bad news about my health. I wish a person had delivered it

Where does female orgasm come from? Scientists think they know

FDA approval of Sarepta Duchenne genetic therapy gives me hope

FDA approves first blood sugar monitor without finger pricks

Supreme Court strikes down use of affirmative action

Inside the culture of fear in the White House science office of Eric Lander

Moonlake's readout produced a cash windfall. Risks remain

NIH director takes cautious approach to Biden drug pricing priority

Wikipedia

What to make of Gilead’s Trodelvy troubles and Elevation Oncology’s rise

Charges dismissed against white woman who spat on Black woman during protests in Connecticut

Francis Collins on trust in science and how Covid communications failed

The tragedy of Johnson & Johnson’s Covid vaccine

Elizabeth Holmes banned from government health programs

Charges dismissed against white woman who spat on Black woman during protests in Connecticut

entertainment

knowledge

leisure time

entertainment